CHEMBL191

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkbp:approvedBy 1976
gptkbp:ATCCode gptkb:C07AB03
gptkbp:availableOn gptkb:tablet
oral solution
gptkbp:bioavailability 50% (oral)
gptkbp:CASNumber gptkb:29122-68-7
gptkbp:color white
gptkbp:contraindication bradycardia
cardiogenic shock
second- or third-degree heart block
hypersensitivity to atenolol
gptkbp:drugClass beta blocker
gptkbp:eliminationHalfLife 6-7 hours
gptkbp:excretion gptkb:kidney
gptkbp:hasInChIKey METKIMKYRPQLGS-UHFFFAOYSA-N
gptkbp:hasLogP 0.16
gptkbp:hasMolecularFormula C14H22N2O3
gptkbp:hasSMILES CC(C)NCC(COC1=CC=CC=C1O)O
gptkbp:hasUNII 50VV3VW0TI
https://www.w3.org/2000/01/rdf-schema#label CHEMBL191
gptkbp:indication gptkb:arrhythmia
myocardial infarction
hypertension
angina pectoris
migraine prophylaxis
gptkbp:isApprovedDrug true
gptkbp:isSolubleIn gptkb:water
gptkbp:listedOn gptkb:WHO_Model_List_of_Essential_Medicines
gptkbp:manufacturer gptkb:AstraZeneca
gptkbp:mechanismOfAction beta-1 adrenergic receptor antagonist
gptkbp:meltingPoint 152-155°C
gptkbp:molecularWeight 266.34
gptkbp:name gptkb:Atenolol
gptkbp:pregnancyCategory D (US)
gptkbp:proteinBinding 6-16%
gptkbp:PubChem_CID gptkb:D00222
2076
2162
DB00335
CHEBI:2268
gptkbp:routeOfAdministration oral
gptkbp:sideEffect dizziness
fatigue
hypotension
bradycardia
cold extremities
gptkbp:synonym gptkb:Atenololum
gptkb:Tenormin
gptkbp:target gptkb:Beta-1_adrenergic_receptor
gptkbp:wasPatentedIn 1969
gptkbp:bfsParent gptkb:acyclovir
gptkbp:bfsLayer 6